Growth Metrics

Carlsmed (CARL) Gross Margin (2024 - 2026)

Carlsmed posted quarterly Gross Margin of 77.1% for Q1 2026, up 215.0% year-on-year from 24.48% in Q1 2025, and up 0.72% on a QoQ basis from 76.54% in Q4 2025.

Carlsmed (CARL) has 3 years of Gross Margin data on file, last reported at 77.1% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin rose 215.0% year-over-year to 77.1%; the trailing twelve-month figure through Mar 2026 stood at 75.89% (up 145.0% YoY), and the FY2025 full-year result was 75.31%, up 151.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 77.1%, up from 76.54% in the prior quarter.
  • Across five years, Gross Margin topped out at 77.1% in Q1 2026 and bottomed at 72.81% in Q3 2024.
  • The 3-year median for Gross Margin is 74.98% (2024), against an average of 75.05%.
  • Peak annual rise in Gross Margin reached 312 bps in 2025, while the deepest fall reached 162 bps in 2025.
  • A 3-year view of Gross Margin shows it stood at 74.66% in 2024, then climbed by 3 bps to 76.54% in 2025, then advanced by 1 bps to 77.1% in 2026.
  • The last three Gross Margin figures came in at 77.1% (Q1 2026), 76.54% (Q4 2025), and 75.93% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 74.46%
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 13.34%
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 72.27%
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 84.60%
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 86.65%
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 85.40%
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 70.39%
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 98.65%
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 45.30%
10 Carlsmed 298.68 Mn 201.48 Mn 12.43 Mn 77.10%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 77.10%
Dec 31, 2025 76.54%
Sep 30, 2025 75.93%
Jun 30, 2025 73.40%
Mar 31, 2025 74.94%
Dec 31, 2024 74.66%
Sep 30, 2024 72.81%
Jun 30, 2024 75.02%